Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium

Ariela Noy, Shelly Y. Lensing, Page C. Moore, Neel Gupta, David Aboulafia, Richard Ambinder, Robert Baiocchi, Bruce J. Dezube, David Henry, Lawrence Kaplan, Alexandra M. Levine, Ronald Mitsuyasu, Lee Ratner, Erin Reid, Scot Remick, Joseph Sparano, Dimitrios Tzachanis, William Wachsman, Amy Chadburn

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)1731-1734
Number of pages4
JournalLeukemia and Lymphoma
Volume57
Issue number7
DOIs
StatePublished - Jul 2 2016

Keywords

  • HIV
  • highly active antiretroviral therapy
  • lymphoma
  • plasmablastic

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Noy, A., Lensing, S. Y., Moore, P. C., Gupta, N., Aboulafia, D., Ambinder, R., Baiocchi, R., Dezube, B. J., Henry, D., Kaplan, L., Levine, A. M., Mitsuyasu, R., Ratner, L., Reid, E., Remick, S., Sparano, J., Tzachanis, D., Wachsman, W., & Chadburn, A. (2016). Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leukemia and Lymphoma, 57(7), 1731-1734. https://doi.org/10.3109/10428194.2015.1113281